FORWARD FEATURES CALENDAR

Exits

Equistone and LDC sell Winterbotham Darby to PAI Partners

Equistone Partners Europe (Equistone), a European mid-market private equity firm, is to sell its majority shareholding in Winterbotham Darby, a supplier of chilled foods to UK supermarket chains, to PAI Partners (PAI).  LDC will also exit its minority shareholding in Winterbotham Darby alongside Equistone, while the company’s management will remain

Bancroft Private Equity exits Rubik

Bancroft Bridge Fund, a private equity  fund managed by Vienna based Bancroft Private Equity, has sold its stake in Rubik’s Brand Ltd (RBL), the London based company that owns the rights to the world famous Rubik’s Cube, to Spin Master Corp (Spin Master), a global children’s entertainment company.  RBL was established

ECI’s MPM exit delivers a 4.4x return

ECI Partners has exchanged on the sale of MPM to 3i Group plc for a return of 4.4x, with completion subject to regulatory clearance.Manchester-headquartered MPM produces premium, natural pet food for discerning cat and dog owners under the Applaws, Encore and Reveal brands. MPM’s products are sold across 50 countries

Hg to sell Eucon to VHV Group

European software investor Hg has agreed the sale of Eucon Group to VHV Group, a German insurance company. The terms of the transaction, which is subject to customary anti-trust approvals and is expected to close later this year, have not been disclosed. Eucon is a leading provider of best-in-class information and

Merck to acquire Pappas Capital portfolio company VelosBio in USD2.75bn deal

Pappas Capital’s portfolio company, VelosBio Inc (VelosBio), is to be acquired by a subsidiary of Merck for USD2.75 billion in cash, subject to customary adjustments. The exit is amongst Pappas Capital’s most successful in its 25-plus-year history.   VelosBio is a clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting

Eurazeo sells entire stake in Farfetch

Eurazeo has completed the sale of all its shares in Farfetch, a Eurazeo Growth portfolio company.This disposal resulted in net proceeds of EUR90.4 million, corresponding to a multiple of 4.1x cash-on-cash and an IRR of around 38 per cent. It is the second portfolio exit for Eurazeo Growth, after PeopleDoc

Key Capital Partners exits Hallam Medical

Key Capital Partners (KCP) has exited Hallam Medical though a management buy-out backed by ABN Amro, delivering a healthy return for investors.Sheffield-based Hallam Medical is a healthcare staffing business which deploys highly qualified nurses, largely Advanced Nurse Practitioners, Community Care Specialists and Telephone Triage Clinical Advisors. KCP backed Hallam in

LDC exits Ellis Whittam to Marlowe plc

 Mid-market private equity firm LDC has exited its investment in Cheshire-based employment specialist Ellis Whittam (EW) to Marlowe plc. The exit follows a successful four-year partnership that saw EW accelerate organic growth and expand its position as a leader in high quality subscription-based compliance services.   Founded in 2004 by solicitor

Octopus Ventures exits Calastone investment to Carlyle Group

Octopus Ventures, part of Octopus Group and one of the largest and most active VCs in Europe, has exited its investment in Calastone, the global funds network, after a majority stake in the funds network was acquired by The Carlyle Group. The transaction is subject to regulatory approval. Octopus Ventures first

Events

12 November, 2026 – 5:00 pm

Directory Listings